Silibinin pretreatment protects against Ochratoxin A-mediated apoptosis in primary rat hepatocytes
The inhibitory effect of silibinin on ochratoxin A (OTA)-mediated apoptosis on primary rat hepatocytes was investigated. Rat hepatocytes were prepared by two different methods: the classical enzymatic digestion method by collagenase perfusion and a new EDTA-perfusion method. The EDTA-perfusion metho...
Gespeichert in:
Veröffentlicht in: | Mycotoxin research 2011-08, Vol.27 (3), p.167-176 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 176 |
---|---|
container_issue | 3 |
container_start_page | 167 |
container_title | Mycotoxin research |
container_volume | 27 |
creator | Essid, E Petzinger, E |
description | The inhibitory effect of silibinin on ochratoxin A (OTA)-mediated apoptosis on primary rat hepatocytes was investigated. Rat hepatocytes were prepared by two different methods: the classical enzymatic digestion method by collagenase perfusion and a new EDTA-perfusion method. The EDTA-perfusion method yielded hepatocytes, which were stably cultivated without DNA fragmentation for up to 96 h, whereas the collagenase-prepared hepatocytes showed apoptosis events as early as from the start of preparation even in the absence of OTA. Treatment with 12.5 μmol/l OTA of cultured hepatocytes prepared under ETDA perfusion developed DNA-laddering after 24–36 h. Lipopolysaccharide (LPS) of 0.1 up to 12.5 μg/ml showed no apoptotic DNA-effects under these conditions. A low concentration of 26 μmol/l silibinin given prior to OTA slightly prevented OTA-mediated DNA-laddering, whereas a five times higher concentration of silibinin (130 μmol/l) completely inhibited OTA-mediated apoptosis. Under the same conditions, caspase-3 activity in hepatocytes increased in a time-dependent manner under OTA exposure within 12–24 h but was blocked by 130 μmol/l silibinin. In contrast, LPS incubation for 12 and 24 h did not alter caspase-3 activity. To measure viability of OTA-/LPS-treated hepatocytes, the MTT-test and Live/Dead kit were applied. The results demonstrated that the used OTA concentration of 12.5 μmol/l only moderately decreased viability for up to 24 h but showed cytotoxic effects depending on longer incubation times (≥36 h). In contrast, LPS up to 12.5 μg/ml exhibited no cytotoxic effects up to 48 h. In summary, our results showed contrasting effects on apoptosis in primary rat hepatocytes by OTA (produces apoptosis) versus LPS (produces no apoptosis), also depending on the method of hepatocyte preparation. Silibinin at 130 μmol/l showed significant hepatoprotective and antiapoptotic effects against OTA-mediated cell damage on cultured rat hepatocytes. |
doi_str_mv | 10.1007/s12550-011-0092-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_883024444</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>883024444</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3429-a837518c495238652102f61fd33236e5e71e57b9bffec41c1c0ed41b531eab2e3</originalsourceid><addsrcrecordid>eNp9kMtOHDEQRa0oURgeH5BN0mLDykmV3X70EiEgSEgsCGvL7akejGa6J7ZHgr-PSU8SiUW8sSyfur4-jH1C-IoA5ltGoRRwQOQAneDdO7ZAqw1HLcV7tgA0lhtr7QE7zPkJQMtW24_sQEgNynR6wfr7uI59HOPYbBOVRL5saCz1MBUKJTd-5eOYS3MXHpMv03MFz_mGltEXWjZ-O23LlGNufgfEjU8vTeWaR9pWOrwUysfsw-DXmU72-xF7uLr8cfGd395d31yc3_IgW9Fxb6VRaEPbKSGtVgJBDBqHpZS1LikySMr0XT8MFFoMGICWLfZKIvlekDxiZ3Nu7f5zR7m4TcyB1ms_0rTLzloJoq2rkqdvyKdpl8ZazlmjtKhabYVwhkKack40uP3_HIJ71e9m_a7qd6_6XVdnPu-Dd3119Hfij-8KiBnI9WpcUfr38v9Sv8xDg5-cX6WY3cO9AGwBwHbSSvkLcf6ZrA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>875621258</pqid></control><display><type>article</type><title>Silibinin pretreatment protects against Ochratoxin A-mediated apoptosis in primary rat hepatocytes</title><source>SpringerLink Journals - AutoHoldings</source><creator>Essid, E ; Petzinger, E</creator><creatorcontrib>Essid, E ; Petzinger, E</creatorcontrib><description>The inhibitory effect of silibinin on ochratoxin A (OTA)-mediated apoptosis on primary rat hepatocytes was investigated. Rat hepatocytes were prepared by two different methods: the classical enzymatic digestion method by collagenase perfusion and a new EDTA-perfusion method. The EDTA-perfusion method yielded hepatocytes, which were stably cultivated without DNA fragmentation for up to 96 h, whereas the collagenase-prepared hepatocytes showed apoptosis events as early as from the start of preparation even in the absence of OTA. Treatment with 12.5 μmol/l OTA of cultured hepatocytes prepared under ETDA perfusion developed DNA-laddering after 24–36 h. Lipopolysaccharide (LPS) of 0.1 up to 12.5 μg/ml showed no apoptotic DNA-effects under these conditions. A low concentration of 26 μmol/l silibinin given prior to OTA slightly prevented OTA-mediated DNA-laddering, whereas a five times higher concentration of silibinin (130 μmol/l) completely inhibited OTA-mediated apoptosis. Under the same conditions, caspase-3 activity in hepatocytes increased in a time-dependent manner under OTA exposure within 12–24 h but was blocked by 130 μmol/l silibinin. In contrast, LPS incubation for 12 and 24 h did not alter caspase-3 activity. To measure viability of OTA-/LPS-treated hepatocytes, the MTT-test and Live/Dead kit were applied. The results demonstrated that the used OTA concentration of 12.5 μmol/l only moderately decreased viability for up to 24 h but showed cytotoxic effects depending on longer incubation times (≥36 h). In contrast, LPS up to 12.5 μg/ml exhibited no cytotoxic effects up to 48 h. In summary, our results showed contrasting effects on apoptosis in primary rat hepatocytes by OTA (produces apoptosis) versus LPS (produces no apoptosis), also depending on the method of hepatocyte preparation. Silibinin at 130 μmol/l showed significant hepatoprotective and antiapoptotic effects against OTA-mediated cell damage on cultured rat hepatocytes.</description><identifier>ISSN: 0178-7888</identifier><identifier>EISSN: 1867-1632</identifier><identifier>DOI: 10.1007/s12550-011-0092-9</identifier><identifier>PMID: 23605796</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Apoptosis ; Biomedical and Life Sciences ; Caspase-3 ; Chemistry/Food Science ; Collagen ; Collagenase ; Cytotoxicity ; Deoxyribonucleic acid ; DNA ; DNA fragmentation ; Hepatocytes ; Life Sciences ; Lipopolysaccharides ; Liver ; Medical Microbiology ; Medicine/Public Health ; Microbiology ; Mycotoxins ; Ochratoxin A ; Original Paper ; Perfusion ; Phytochemicals ; rats ; Rodents ; silibinin ; Toxins</subject><ispartof>Mycotoxin research, 2011-08, Vol.27 (3), p.167-176</ispartof><rights>Society for Mycotoxin Research and Springer 2011</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3429-a837518c495238652102f61fd33236e5e71e57b9bffec41c1c0ed41b531eab2e3</citedby><cites>FETCH-LOGICAL-c3429-a837518c495238652102f61fd33236e5e71e57b9bffec41c1c0ed41b531eab2e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12550-011-0092-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12550-011-0092-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27923,27924,41487,42556,51318</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23605796$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Essid, E</creatorcontrib><creatorcontrib>Petzinger, E</creatorcontrib><title>Silibinin pretreatment protects against Ochratoxin A-mediated apoptosis in primary rat hepatocytes</title><title>Mycotoxin research</title><addtitle>Mycotox Res</addtitle><addtitle>Mycotoxin Res</addtitle><description>The inhibitory effect of silibinin on ochratoxin A (OTA)-mediated apoptosis on primary rat hepatocytes was investigated. Rat hepatocytes were prepared by two different methods: the classical enzymatic digestion method by collagenase perfusion and a new EDTA-perfusion method. The EDTA-perfusion method yielded hepatocytes, which were stably cultivated without DNA fragmentation for up to 96 h, whereas the collagenase-prepared hepatocytes showed apoptosis events as early as from the start of preparation even in the absence of OTA. Treatment with 12.5 μmol/l OTA of cultured hepatocytes prepared under ETDA perfusion developed DNA-laddering after 24–36 h. Lipopolysaccharide (LPS) of 0.1 up to 12.5 μg/ml showed no apoptotic DNA-effects under these conditions. A low concentration of 26 μmol/l silibinin given prior to OTA slightly prevented OTA-mediated DNA-laddering, whereas a five times higher concentration of silibinin (130 μmol/l) completely inhibited OTA-mediated apoptosis. Under the same conditions, caspase-3 activity in hepatocytes increased in a time-dependent manner under OTA exposure within 12–24 h but was blocked by 130 μmol/l silibinin. In contrast, LPS incubation for 12 and 24 h did not alter caspase-3 activity. To measure viability of OTA-/LPS-treated hepatocytes, the MTT-test and Live/Dead kit were applied. The results demonstrated that the used OTA concentration of 12.5 μmol/l only moderately decreased viability for up to 24 h but showed cytotoxic effects depending on longer incubation times (≥36 h). In contrast, LPS up to 12.5 μg/ml exhibited no cytotoxic effects up to 48 h. In summary, our results showed contrasting effects on apoptosis in primary rat hepatocytes by OTA (produces apoptosis) versus LPS (produces no apoptosis), also depending on the method of hepatocyte preparation. Silibinin at 130 μmol/l showed significant hepatoprotective and antiapoptotic effects against OTA-mediated cell damage on cultured rat hepatocytes.</description><subject>Apoptosis</subject><subject>Biomedical and Life Sciences</subject><subject>Caspase-3</subject><subject>Chemistry/Food Science</subject><subject>Collagen</subject><subject>Collagenase</subject><subject>Cytotoxicity</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>DNA fragmentation</subject><subject>Hepatocytes</subject><subject>Life Sciences</subject><subject>Lipopolysaccharides</subject><subject>Liver</subject><subject>Medical Microbiology</subject><subject>Medicine/Public Health</subject><subject>Microbiology</subject><subject>Mycotoxins</subject><subject>Ochratoxin A</subject><subject>Original Paper</subject><subject>Perfusion</subject><subject>Phytochemicals</subject><subject>rats</subject><subject>Rodents</subject><subject>silibinin</subject><subject>Toxins</subject><issn>0178-7888</issn><issn>1867-1632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kMtOHDEQRa0oURgeH5BN0mLDykmV3X70EiEgSEgsCGvL7akejGa6J7ZHgr-PSU8SiUW8sSyfur4-jH1C-IoA5ltGoRRwQOQAneDdO7ZAqw1HLcV7tgA0lhtr7QE7zPkJQMtW24_sQEgNynR6wfr7uI59HOPYbBOVRL5saCz1MBUKJTd-5eOYS3MXHpMv03MFz_mGltEXWjZ-O23LlGNufgfEjU8vTeWaR9pWOrwUysfsw-DXmU72-xF7uLr8cfGd395d31yc3_IgW9Fxb6VRaEPbKSGtVgJBDBqHpZS1LikySMr0XT8MFFoMGICWLfZKIvlekDxiZ3Nu7f5zR7m4TcyB1ms_0rTLzloJoq2rkqdvyKdpl8ZazlmjtKhabYVwhkKack40uP3_HIJ71e9m_a7qd6_6XVdnPu-Dd3119Hfij-8KiBnI9WpcUfr38v9Sv8xDg5-cX6WY3cO9AGwBwHbSSvkLcf6ZrA</recordid><startdate>201108</startdate><enddate>201108</enddate><creator>Essid, E</creator><creator>Petzinger, E</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T7</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>P64</scope><scope>PATMY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PYCSY</scope><scope>Q9U</scope></search><sort><creationdate>201108</creationdate><title>Silibinin pretreatment protects against Ochratoxin A-mediated apoptosis in primary rat hepatocytes</title><author>Essid, E ; Petzinger, E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3429-a837518c495238652102f61fd33236e5e71e57b9bffec41c1c0ed41b531eab2e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Apoptosis</topic><topic>Biomedical and Life Sciences</topic><topic>Caspase-3</topic><topic>Chemistry/Food Science</topic><topic>Collagen</topic><topic>Collagenase</topic><topic>Cytotoxicity</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>DNA fragmentation</topic><topic>Hepatocytes</topic><topic>Life Sciences</topic><topic>Lipopolysaccharides</topic><topic>Liver</topic><topic>Medical Microbiology</topic><topic>Medicine/Public Health</topic><topic>Microbiology</topic><topic>Mycotoxins</topic><topic>Ochratoxin A</topic><topic>Original Paper</topic><topic>Perfusion</topic><topic>Phytochemicals</topic><topic>rats</topic><topic>Rodents</topic><topic>silibinin</topic><topic>Toxins</topic><toplevel>online_resources</toplevel><creatorcontrib>Essid, E</creatorcontrib><creatorcontrib>Petzinger, E</creatorcontrib><collection>AGRIS</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database (ProQuest)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><jtitle>Mycotoxin research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Essid, E</au><au>Petzinger, E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Silibinin pretreatment protects against Ochratoxin A-mediated apoptosis in primary rat hepatocytes</atitle><jtitle>Mycotoxin research</jtitle><stitle>Mycotox Res</stitle><addtitle>Mycotoxin Res</addtitle><date>2011-08</date><risdate>2011</risdate><volume>27</volume><issue>3</issue><spage>167</spage><epage>176</epage><pages>167-176</pages><issn>0178-7888</issn><eissn>1867-1632</eissn><abstract>The inhibitory effect of silibinin on ochratoxin A (OTA)-mediated apoptosis on primary rat hepatocytes was investigated. Rat hepatocytes were prepared by two different methods: the classical enzymatic digestion method by collagenase perfusion and a new EDTA-perfusion method. The EDTA-perfusion method yielded hepatocytes, which were stably cultivated without DNA fragmentation for up to 96 h, whereas the collagenase-prepared hepatocytes showed apoptosis events as early as from the start of preparation even in the absence of OTA. Treatment with 12.5 μmol/l OTA of cultured hepatocytes prepared under ETDA perfusion developed DNA-laddering after 24–36 h. Lipopolysaccharide (LPS) of 0.1 up to 12.5 μg/ml showed no apoptotic DNA-effects under these conditions. A low concentration of 26 μmol/l silibinin given prior to OTA slightly prevented OTA-mediated DNA-laddering, whereas a five times higher concentration of silibinin (130 μmol/l) completely inhibited OTA-mediated apoptosis. Under the same conditions, caspase-3 activity in hepatocytes increased in a time-dependent manner under OTA exposure within 12–24 h but was blocked by 130 μmol/l silibinin. In contrast, LPS incubation for 12 and 24 h did not alter caspase-3 activity. To measure viability of OTA-/LPS-treated hepatocytes, the MTT-test and Live/Dead kit were applied. The results demonstrated that the used OTA concentration of 12.5 μmol/l only moderately decreased viability for up to 24 h but showed cytotoxic effects depending on longer incubation times (≥36 h). In contrast, LPS up to 12.5 μg/ml exhibited no cytotoxic effects up to 48 h. In summary, our results showed contrasting effects on apoptosis in primary rat hepatocytes by OTA (produces apoptosis) versus LPS (produces no apoptosis), also depending on the method of hepatocyte preparation. Silibinin at 130 μmol/l showed significant hepatoprotective and antiapoptotic effects against OTA-mediated cell damage on cultured rat hepatocytes.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>23605796</pmid><doi>10.1007/s12550-011-0092-9</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0178-7888 |
ispartof | Mycotoxin research, 2011-08, Vol.27 (3), p.167-176 |
issn | 0178-7888 1867-1632 |
language | eng |
recordid | cdi_proquest_miscellaneous_883024444 |
source | SpringerLink Journals - AutoHoldings |
subjects | Apoptosis Biomedical and Life Sciences Caspase-3 Chemistry/Food Science Collagen Collagenase Cytotoxicity Deoxyribonucleic acid DNA DNA fragmentation Hepatocytes Life Sciences Lipopolysaccharides Liver Medical Microbiology Medicine/Public Health Microbiology Mycotoxins Ochratoxin A Original Paper Perfusion Phytochemicals rats Rodents silibinin Toxins |
title | Silibinin pretreatment protects against Ochratoxin A-mediated apoptosis in primary rat hepatocytes |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T04%3A35%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Silibinin%20pretreatment%20protects%20against%20Ochratoxin%20A-mediated%20apoptosis%20in%20primary%20rat%20hepatocytes&rft.jtitle=Mycotoxin%20research&rft.au=Essid,%20E&rft.date=2011-08&rft.volume=27&rft.issue=3&rft.spage=167&rft.epage=176&rft.pages=167-176&rft.issn=0178-7888&rft.eissn=1867-1632&rft_id=info:doi/10.1007/s12550-011-0092-9&rft_dat=%3Cproquest_cross%3E883024444%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=875621258&rft_id=info:pmid/23605796&rfr_iscdi=true |